-
1
MYC dependency in GLS1 and NAMPT is a therapeutic vulnerability in multiple myeloma
Published 2024-04-01Get full text
Article -
2
-
3
-
4
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
Published 2022-07-01Get full text
Article -
5
-
6
Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology
Published 2018-12-01Get full text
Article -
7
Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?
Published 2021-12-01Get full text
Article -
8
-
9